Clinical Trial Update: Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating modified bone marrow stem cell transplantation for chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Myeloid Leukemia, Graft vs Host Disease | Phase 2 | Status: COMPLETED